Atea Pharmaceuticals
AVIR
#7534
Rank
A$0.43 B
Marketcap
$5.10
Share price
-0.89%
Change (1 day)
12.73%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -A$0.27 Billion

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.21 Billion a decrease over its 2022 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.27 Billion28.18%
2023 -A$0.21 Billion12.92%
2022 -A$0.19 Billion-186.22%
2021 A$0.21 B-1366.01%
2020 -A$16.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA